Christina has diverse clinical operations experience at the site, vendor, and Sponsor levels of research. Prior to InCarda, Christina was at Gilead Sciences, where she led a global Phase 2 rheumatoid arthritis study. Prior to Gilead, Christina was at BioMarin supporting studies in oncology and rare diseases and at QuantifiCare, where she managed photography sub-studies across oncology, ABSSSI, psoriasis, and aesthetics. Christina also previously led data management and protocol compliance oversight activities for sarcoma, lung cancer, and Phase 1 solid tumor clinical trials as a Data Manager at UCLA.
Christina previously served on a Patient Advisory Board for Octopharma, currently serves on the Research Committee of the VWD Connect Foundation, and is co-Principal Investigator for the VWD Connect Foundation’s Severe Von Willebrand Disease Patient Registry.
Christina holds a B.S. in Geology from San Jose State University, an M.S. in Biotechnology from Johns Hopkins University, and an Executive M.B.A. from Quantic School of Business and Technology.